ISAACS, D. J.; KATHURIA-PRAKASH, N.; HILDER, R.; LECHNER, M. G.; DRAKAKI, A. Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy. Current Cancer Reports, v. 5, n. 1, p. 168-180, 29 jan. 2024.